Shopping Cart
- Remove All
- Your shopping cart is currently empty
HSD17B13-IN-93 (Compound 9) acts as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC 50 for estradiol ranging between greater than 0.1 μM and up to 0.5 μM. Its application extends to the study of liver, metabolic, and cardiovascular diseases including NAFLD and NASH, alongside drug-induced liver injury (DILI) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | HSD17B13-IN-93 (Compound 9) acts as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC 50 for estradiol ranging between greater than 0.1 μM and up to 0.5 μM. Its application extends to the study of liver, metabolic, and cardiovascular diseases including NAFLD and NASH, alongside drug-induced liver injury (DILI) [1]. |
Molecular Weight | 473.83 |
Formula | C19H12ClF4N3O3S |
Cas No. | 2848620-87-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.